Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma (CC# 10852)

This study has been completed.
Information provided by (Responsible Party):
Adil Daud, University of California, San Francisco Identifier:
First received: July 28, 2010
Last updated: December 11, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)